Flow cytometric analysis of the multiple drug resistance phenotype

Leukemia

Volumn 11, Issue 7, 1997, Pages 1138-1146

  Krishan, A ^a   Sauerteig, A ^a   Andritsch, I ^a   Wellham, L ^a  

^a UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

Author keywords

Anthracyclines; Efflux; Flow cytometry; Fluorescence; MDR; P glycoprotein

Indexed keywords

DAUNORUBICIN; DIPYRIDAMOLE; DOXORUBICIN; FLUOROCHROME; GLYCOPROTEIN P; NSC 821151; PROCHLORPERAZINE MALEATE; TRIFLUOPERAZINE; UNCLASSIFIED DRUG; VERAPAMIL; VINBLASTINE SULFATE;

ANIMAL CELL; ARTICLE; ARTIFACT; DRUG ACCUMULATION; FLOW CYTOMETRY; HUMAN; HUMAN CELL; LASER; MOUSE; MULTIDRUG RESISTANCE; NONHUMAN; PRIORITY JOURNAL;

EID: 0030737595     PISSN: 08876924     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.leu.2400684     Document Type: Article

References (25)

1. Gottesman MM. How cancer cells evade chemotherapy: sixteenth Richard and Hinda Rosenthal Foundation Award Lecture (review). Cancer Res 1993; 53: 747-754.
2. Ling V. P-glycoprotein and resistance to anticancer drugs. Cancer 1992; 69: 2603-2609.
3. Cole SPC, Sparks KE, Fraser K, Loe DW, Grant CE, Wilson CM, Deeley RG. Pharmacological characterization of multidrug resistant MRP-transfected human tumor cells. Cancer Res 1994; 54: 5902-5910.
4. Scheffer GL, Wijngaard PLJ, Flens MJ, Izquierdo MA, Slovak ML, Pinedo HM, Meijer CJLM, Clevers HC, Scheper RJ. The drug resistance-related protein LRP is the human major vault protein. Nature Med 1995; 1: 578-582.
5. Krishan A, Ganapathi R. Laser flow cytometric studies on intracellular fluorescence of anthracyclines. Cancer Res 1980; 40: 3895-3900.
6. Krishan A, Sridhar KS, Davila E, Vogel C, Sternheim W. Patterns of anthracycline retention modulation in human tumor cells. Cytometry 1987; 8: 306-314.
7. Durand RE. Flow cytometry studies of intracellular adriamycin in multicell spheroids in vitro. Cancer Res 1981; 41. 3495-3498.
8. Herweijer H, Van Den Engh G, Nooter K. A rapid and sensitive flow cytometric method for the detection of multidrug-resistant cells. Cytometry 1989; 10: 463-468.
9. Noonan KE, Beck C, Holzmayer TA, Chin JE, Wunder JS, Andrulis IL, Gazdar AF, Willman CL, Griffith B, Von Hoff DD. Quantitative analysis of MDR1 (multidrug resistance) gene expression in human tumors by polymerase chain reaction. Proc Natl Acad Sci USA 1990; 87: 7160-7164.
10. Krishan A, Sauerteig A, Stein JH. Comparison of three commercially available antibodies for flow cytometric monitoring of P-glycoprotein expression in tumor cells. Cytometry 1991; 12: 731-742.
11. Hamada H, Tsuruo T. Purification of the 170- to 180-kilodalton membrane glycoprotein associated with multidrug resistance. J Biol Chem 1988; 263: 1454-1458.
12. Arceci RJ, Stieglitz K, Bras J, Schinkel A, Baas F, Croop J. Monoclonal antibody to an external epitope of the human Mdr1 P-glycoprotein. Cancer Res 1993; 53: 310-317.
13. Mechetner EB, Roninson IB. Efficient inhibition of P-glycoprotein-mediated multidrug resistance with a monoclonal antibody. Proc Natl Acad Sci USA 1992; 89: 5824-5828.
14. Beck WT, Mueller TJ, Tanzer LR. Altered membrane glycoproteins in vinca-alkaloid resistant human leukemic lymphoblast (CCRFCEM). Cancer Res 1979; 39: 2070-2076.
15. Leibovitz A, Stinson JC, McCombs WB III, McCoy CE, Mazur KC, Mabry ND. Classification of human colorectal adenocarcinoma cell lines. Cancer Res 1976, 36: 4562-4569.
16. Tibbets LM, Chu MY, Hager JC, Dexter DL, Calabresi P. Chemotherapy of cell-line derived human colon carcinomas in mice immunosuppressed with anlithymocyte serum. Cancer 1977; 40: 2651-2659.
17. Chaudhary PM, Roninson IB. Expression and activity of P-glycoprotein, a multidrug efflux pump, in human hematopoietic stem cells. Cell 1991; 66: 85-94.
18. Lampidis T, Munck J, Krishan A, Tapiero H. Reversal of resistance to rhodamine 123 in adriamycin-resistant Friend leukemia cells. Cancer Res 1985; 45: 2626-2631.
19. Frey T, Yue S, Haugland RP. Dyes providing increased sensitivity in flow-cytometric dye-efflux assays for multidrug resistance. Cytometry 1995; 20: 218-227.
20. Cordon-Cardo C, O'Brien JP, Casals D, Rittman-Grauer L, Biedler JLM, Bertino JR. Multidrug-resistance gene (P-glycoprotein) is expressed by endothelial cells at blood-brain barrier sites. Proc Natl Acad Sci USA 1988; 86: 695-698.
21. Schlaifer D, Laurent G, Chittal S, Tsuruo T, Soues S, Muller C, Charcosset JY, Alard C, Brousset P, Mazerrolles C, Delsol G. Immunohistochemical detection of multidrug resistance associated P-glycoprotein in tumour and stromal cells of human cancers Br J Cancer 1990; 62: 177-182.
22. Klimecki WT, Futscher BW, Grogan TM, Dalton WS. P-glycoprotein expression and function in circulating blood cells from normal volunteers. Blood 1994; 83: 2451-2458.
23. Chaudhary PM, Mechetner EB, Roninson IB. Expression and activity of the multidrug resistance P-glycoprotein in human peripheral blood lymphocytes. Blood 1992; 80: 2735-2739.
24. Ramachandran C, Mead D, Wellham L, Sauerteig A, Krishan A. Expression of drug resistance associated mdr-1, GSTπ, and topoisomerase II genes during cell cycle. Biochem Pharm 1995; 49-545-552.
25. Krishan A. Heterogeneity of anthracycline retention and response to efflux blockers in human tumors. Cytometry 1995; 21: 72-75.